📰 Cancer Imaging Program News
Cancer Imaging Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cancer Imaging Program. Real-time updates on events, politics, business and more.
November 10, 2023
Durvalumab plus concurrent transarterial chemoembolization followed by durvalumab with bevacizumab resulted in a significant improvement in PFS over TACE alone in patients with hepatocellular carcinoma who are eligible for embolization, meeting the primary end point of the phase 3 EMERALD-1 trial.
November 9, 2023
Imfinzi plus bevacizumab met primary endpoint for progression-free survival in liver cancer eligible for embolisation in EMERALD-1 Phase III trial
May 11, 2023
The global portable medical devices market is projected to expand at a CAGR of 10.7% during the forecast period. The market is estimated to generate market
February 16, 2021
Date Time Molecular Imaging Determines Effectiveness of Novel Metastatic Breast Cancer Treatment Reston, VA-Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal therapy. According to research published in the February issue of The Journal of Nuclear Medicine, positron emission tomography (PET) imaging using an imaging agent called 18F-fluoroestradiol can help to determine which pa...